HTBX - ヒ―ト・バイオロジクス (Heat Biologics Inc.) ヒ―ト・バイオロジクス

 HTBXのチャート


 HTBXの企業情報

symbol HTBx
会社名 Heat Biologics Inc (ヒ―ト・バイオロジクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ヒート・バイオロジクス(Heat Biologics Inc.)は開発段階のバイオ医薬品会社であり、多様な癌と感染性疾患に有効な同種異系、既製の細胞治療ワクチンの開発に従事する。同社のImmunePan抗原細胞傷害性療法(インパクト)は癌患者の免疫系を活性化して癌性細胞を認識して殺させる一連の癌関連抗原及び「gp96」と呼ばれる免疫アジュバントを送り出すように再プログラムされた遺伝子組換えの被照射ヒト生細胞を送達するために設計されている。同社の主要な製品候補は、「HS-110」と「HS-410」である。同社はまた乳癌と卵巣癌向けの「ImPACT」という治療用ワクチンを開発している。   ヒ―ト・バイオロジクスは開発段階の米国のバイオ医薬品会社。がんや感染症に対応するアロジェニック、およびオフザシェルフ細胞療法ワクチンの開発に注力する。新薬候補には非小細胞性肺がん治療用のHS-110、および膀胱がん治療用のHS-410がある。本社はノ―スカロライナ州。   Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.
本社所在地 801 Capitola Drive Durham NC 27713 USA
代表者氏名 Jeffrey Alan Wolf ジェフリー・アラン・ウルフ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 919-240-7133
設立年月日 39600
市場名 NASDAQ Small Cap
ipoyear 2013年
従業員数 19人
url www.heatbio.com
nasdaq_url https://www.nasdaq.com/symbol/htbx
adr_tso
EBITDA EBITDA(百万ドル) -14.67771
終値(lastsale) 1.88
時価総額(marketcap) 43479293.92
時価総額 時価総額(百万ドル) 40.01020
売上高 売上高(百万ドル) 2.98016
企業価値(EV) 企業価値(EV)(百万ドル) 15.34947
当期純利益 当期純利益(百万ドル) -21.03366
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Heat Biologics Inc revenues increased from $435K to $1.9M. Net loss increased 18% to $7.6M. Revenues reflect Grant and licensing revenue increase from $411K to $1.9M. Higher net loss reflects Research and Development increase of 60% to $6.4M (expense) General and administrative increase of 1% to $3.1M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$2.10 to -$1.02.

 HTBXのテクニカル分析


 HTBXのニュース

   3 Biotech Stocks in the Hunt for COVID-19 Vaccine; One Analyst Calls Them a ‘Buy’  2020/10/30 18:40:57 Yahoo Finance
Nearly a year into a global pandemic the world is still on the back of its heels. In the face of ever increasing infection rates, world economies have slowed rapidly and unemployment has increased significantly, and now governments are reconsidering shutting down entire countries once again. At the same time, the federal government has failed to pass a second stimulus package to prop up individuals who have lost their jobs and may be facing homelessness, as well as the need to help state and local governments provide a backstop against their own losses.Given this backdrop, there is a lot riding on a potential vaccine and/or cure for COVID-19. There are many approaches that a lengthy list of varying companies are taking to bring their respective product to market.Any company that does successfully bring a product to market that helps in the fight against the virus may see a significant increase in revenues as well as an in-kind increase in profits. B. Riley Securities has highlighted three biotech companies that are approaching the virus from different directions.
   Heat Biologics Inc (NASDAQ:HTBX) Receives Consensus Rating of “Buy” from Brokerages  2020/10/24 04:28:43 US Banking News
Shares of Heat Biologics Inc (NASDAQ:HTBX) have received a consensus recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokers […]
   Heat Biologics (NASDAQ:HTBX) Stock Price Down 6.7%  2020/10/21 19:38:43 The Olympia Report
Heat Biologics Inc (NASDAQ:HTBX) shares traded down 6.7% on Wednesday . The company traded as low as $1.11 and last traded at $1.11. 4,246,283 shares changed hands during trading, a decline of 75% from the average session volume of 17,276,072 shares. The stock had previously closed at $1.19. A number of equities research analysts have […]
   Heat Biologics : Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator | MarketScreener  2020/10/07 11:40:02 MarketScreener
October 7, 2020 Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cellCo-Stimulator New patent covers ICOS… | October 7, 2020
   COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020 Featuring Major Players - Pfizer, GSK, Inovio Pharma, J&J, Novavax, Heat Biologics, Sanofi, BioNTech, Vaxart, and Vir Biotechnology - ResearchAndMarkets.com  2020/09/30 13:26:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020" report has been added to ResearchAndMarkets.com's offering. COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020 provides the strategists, marketers and senior management with the critical information they need to assess the global COVID-19 vaccine & therapeutics clinical trial analysis 2020 market. Major players in the COVID-19 vaccine and therapeutics clinical trial analysis market
   3 Biotech Stocks in the Hunt for COVID-19 Vaccine; One Analyst Calls Them a ‘Buy’  2020/10/30 18:40:57 Yahoo Finance
Nearly a year into a global pandemic the world is still on the back of its heels. In the face of ever increasing infection rates, world economies have slowed rapidly and unemployment has increased significantly, and now governments are reconsidering shutting down entire countries once again. At the same time, the federal government has failed to pass a second stimulus package to prop up individuals who have lost their jobs and may be facing homelessness, as well as the need to help state and local governments provide a backstop against their own losses.Given this backdrop, there is a lot riding on a potential vaccine and/or cure for COVID-19. There are many approaches that a lengthy list of varying companies are taking to bring their respective product to market.Any company that does successfully bring a product to market that helps in the fight against the virus may see a significant increase in revenues as well as an in-kind increase in profits. B. Riley Securities has highlighted three biotech companies that are approaching the virus from different directions.
   Heat Biologics Inc (NASDAQ:HTBX) Receives Consensus Rating of “Buy” from Brokerages  2020/10/24 04:28:43 US Banking News
Shares of Heat Biologics Inc (NASDAQ:HTBX) have received a consensus recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokers […]
   Heat Biologics (NASDAQ:HTBX) Stock Price Down 6.7%  2020/10/21 19:38:43 The Olympia Report
Heat Biologics Inc (NASDAQ:HTBX) shares traded down 6.7% on Wednesday . The company traded as low as $1.11 and last traded at $1.11. 4,246,283 shares changed hands during trading, a decline of 75% from the average session volume of 17,276,072 shares. The stock had previously closed at $1.19. A number of equities research analysts have […]
   Heat Biologics : Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator | MarketScreener  2020/10/07 11:40:02 MarketScreener
October 7, 2020 Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cellCo-Stimulator New patent covers ICOS… | October 7, 2020
   COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020 Featuring Major Players - Pfizer, GSK, Inovio Pharma, J&J, Novavax, Heat Biologics, Sanofi, BioNTech, Vaxart, and Vir Biotechnology - ResearchAndMarkets.com  2020/09/30 13:26:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020" report has been added to ResearchAndMarkets.com's offering. COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020 provides the strategists, marketers and senior management with the critical information they need to assess the global COVID-19 vaccine & therapeutics clinical trial analysis 2020 market. Major players in the COVID-19 vaccine and therapeutics clinical trial analysis market
   Heat Biologics News: Why HTBX Stock Is On the Move Today  2020/09/17 18:16:04 InvestorPlace
Heat Biologics (HTBX) is in the news Thursday as HTBX stock takes a wild ride following an increasing focus on coronavirus stocks.
   Thinking about buying stock in Heat Biologics, Co-Diagnostics, Penn National Gaming, Boxlight Corp, or Intec Pharma?  2020/08/13 13:31:00 PR Newswire
NEW YORK, Aug. 13, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HTBX, CODX, PENN, BOXL, and NTEC. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Heat Biologics : Provides Second Quarter 2020 Business Update | MarketScreener  2020/08/07 12:22:19 MarketScreener
August 7, 2020 Heat Biologics Provides Second Quarter 2020 Business Update Progress on COVID-19 Vaccine Program … | August 7, 2020
   Heat Biologics Provides Second Quarter 2020 Business Update  2020/08/07 11:00:00 Yahoo Finance
* Progress on COVID-19 Vaccine Program * Reports over $100 million in cash and short-term investments as of August 6, 2020DURHAM, NC / ACCESSWIRE / August 7, 2020 / Heat Biologics, Inc.
   The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat  2020/07/22 11:24:35 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) ABIOMED, Inc. (NASDAQ: ABMD ) Assembly Biosciences Inc (NASDAQ: ASMB ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Catalent Inc (NYSE: CTLT ) CTI BioPharma Corp (NASDAQ: CTIC ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Heat Biologics Inc (NASDAQ: HTBX ) Hologic, Inc. (NASDAQ: HOLX ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) Natera Inc (NASDAQ: NTRA ) Novo Nordisk A/S (NYSE: NVO ) Opko Health Inc. (NASDAQ: OPK )(moved in reaction to an announcement it will offer COVID-19 diagnostics testing to the NFL) ResMed Inc. (NYSE: RMD ) Retrophin Inc (NASDAQ: RTRX ) Trevena Inc (NASDAQ: TRVN ) Twist Bioscience Corp (NASDAQ: TWST ) Veracyte Inc (NASDAQ: VCYT ) West Pharmaceutical Services Inc.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ヒ―ト・バイオロジクス HTBX Heat Biologics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)